Real-life, long-term data on efficacy, safety, response and discontinuation patterns of omalizumab in a Greek population with chronic spontaneous urticaria

被引:0
|
作者
Zoe Apalla
Theodoros Sidiropoulos
Evaggelia Kampouropoulou
Marina Papageorgiou
Aimilios Lallas
Elizabeth Lazaridou
Maria Smaragdi
Florentina Delli
机构
[1] Hippokratio General Hospital of Thessaloniki,State Dermatology Department
[2] Aristotle University of Thessaloniki,First Dermatology Department
[3] Aristotle University of Thessaloniki,Second Dermatology Department
来源
关键词
chronic spontaneous urticaria; urticaria; omalizumab; angioedema; allergy; IgE inhibitors;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:716 / 722
页数:6
相关论文
共 50 条
  • [21] Omalizumab for chronic spontaneous urticaria in "complex" patients: data from real-life clinical practice
    Vollono, Laura
    Piccolo, Arianna
    Lanna, Caterina
    Esposito, Maria
    Bavetta, Mauro
    Campione, Elena
    Bianchi, Luca
    Diluvio, Laura
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2019, 13 : 3181 - 3186
  • [22] Multicentric and Observational Study of Omalizumab for Chronic Spontaneous Urticaria in Real-Life in Colombia
    Garcia-Gomez, Elizabeth
    Chapman, Edgardo
    Garcia-Paba, Maria Beatriz
    Ocampo-Gomez, Jaime
    Egea-Bermejo, Eduardo
    Garavito-De Egea, Gloria
    Fang, Luis
    Sarrazola, Mauricio
    Sanchez-Caraballo, Jorge Mario
    Serrano-Reyes, Carlos
    Silva-Espinosa, Diana Lucia
    Rojas-Mejia, Dolly Vanessa
    Moreno, Sergio M.
    FRONTIERS IN ALLERGY, 2022, 3
  • [23] Long-Term Efficacy of Omalizumab in Patients with Treatment-Resistant Chronic Spontaneous Urticaria
    Al-Ahmad, Mona Sulaiman
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 135 (02) : AB128 - AB128
  • [24] Management of the long-term omalizumab therapy in chronic spontaneous urticaria
    Ensina, L. F.
    Camelo-Nunes, I. C.
    Galeane, M.
    Cusato, A. P.
    Serpa, F. S.
    Sole, D.
    ALLERGY, 2016, 71 : 559 - 559
  • [25] Omalizumab in Chronic Inducible Urticaria: a Real-Life Study of Efficacy, Safety, Predictors of Treatment Outcome, Time to Response and Relapse
    Yu, Miao
    Maurer, Marcus
    Chen, Yudi
    Zhao, Zuotao
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB26 - AB26
  • [26] Omalizumab for severe chronic spontaneous urticaria: Real-life experiences of 280 patients
    Vadasz, Zahava
    Tal, Yuval
    Rotem, Menachem
    Shichter-Confino, Vered
    Mahlab-Guri, Keren
    Graif, Yael
    Kessel, Aharon
    Agmon-Levin, Nancy
    Maoz-Segal, Ramit
    Kivity, Shmuel
    Benor, Shira
    Lachover-Roth, Idit
    Zeldin, Yuri
    Stein, Migel
    Toker, Ori
    Hassoun, Gamal
    Bezalel-Rosenberg, Shira
    Toubi, Elias
    Asher, Ilan
    Sthoeger, Zev
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2017, 5 (06): : 1743 - 1745
  • [27] Omalizumab in elderly patients with chronic spontaneous urticaria: An Italian real-life experience
    Nettis, Eustachio
    Cegolon, Luca
    Di Leo, Elisabetta
    Canonica, Walter Giorgio
    Detoraki, Aikaterini
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 120 (03) : 318 - 323
  • [28] Remission of chronic spontaneous urticaria following omalizumab with gradually extended dosing intervals: Real-life data
    Salman, Andac
    Aktas, Meryem
    Sengun, Ozlem Apti
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2021, 62 (03) : 398 - 402
  • [29] Efficacy of omalizumab in chronic spontaneous urticaria refractory to conventional therapy: analysis of 110 patients in real-life practice
    Labrador-Horrillo, Moises
    Valero, Antonio
    Velasco, Manuel
    Jauregui, Ignacio
    Sastre, Joaquin
    Bartra, Joan
    Francisco Silvestre, Juan
    Ortiz de Frutos, Javier
    Gimenez-Arnau, Ana
    Ferrer, Marta
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2013, 13 (09) : 1225 - 1228
  • [30] Long-term efficacy of fixed-dose omalizumab for patients with severe chronic spontaneous urticaria
    Song, Christine Hahjin
    Stern, Simon
    Giruparajah, Mohana
    Berlin, Noam
    Sussman, Gordon L.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2013, 110 (02) : 113 - 117